Maia Biotechnology Stock Market Value
| MAIA Stock | USD 2.20 0.02 0.92% |
| Symbol | MAIA |
MAIA Biotechnology Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MAIA Biotechnology. If investors know MAIA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MAIA Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.34) | Return On Assets (1.07) | Return On Equity (5.60) |
The market value of MAIA Biotechnology is measured differently than its book value, which is the value of MAIA that is recorded on the company's balance sheet. Investors also form their own opinion of MAIA Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is MAIA Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MAIA Biotechnology's market value can be influenced by many factors that don't directly affect MAIA Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MAIA Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if MAIA Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MAIA Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
MAIA Biotechnology 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to MAIA Biotechnology's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of MAIA Biotechnology.
| 10/30/2024 |
| 11/29/2024 |
If you would invest 0.00 in MAIA Biotechnology on October 30, 2024 and sell it all today you would earn a total of 0.00 from holding MAIA Biotechnology or generate 0.0% return on investment in MAIA Biotechnology over 30 days. MAIA Biotechnology is related to or competes with Lineage Cell, Armata Pharmaceuticals, Portage Biotech, Larimar Therapeutics, Lyra Therapeutics, Genelux Common, and Dyadic International. MAIA Biotechnology, Inc., a clinical stage biotechnology company, engages in the discovery, development, and commerciali... More
MAIA Biotechnology Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure MAIA Biotechnology's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess MAIA Biotechnology upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 28.1 | |||
| Value At Risk | (9.23) | |||
| Potential Upside | 8.37 |
MAIA Biotechnology Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for MAIA Biotechnology's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as MAIA Biotechnology's standard deviation. In reality, there are many statistical measures that can use MAIA Biotechnology historical prices to predict the future MAIA Biotechnology's volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.35) | |||
| Total Risk Alpha | (1.03) | |||
| Treynor Ratio | (0.31) |
MAIA Biotechnology Backtested Returns
MAIA Biotechnology has Sharpe Ratio of -0.0656, which conveys that the company had a -0.0656% return per unit of volatility over the last 3 months. MAIA Biotechnology exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify MAIA Biotechnology's Standard Deviation of 5.14, mean deviation of 3.93, and Market Risk Adjusted Performance of (0.30) to check out the risk estimate we provide. The firm secures a Beta (Market Risk) of 0.83, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, MAIA Biotechnology's returns are expected to increase less than the market. However, during the bear market, the loss of holding MAIA Biotechnology is expected to be smaller as well. At this point, MAIA Biotechnology has a negative expected return of -0.33%. Please make sure to verify MAIA Biotechnology's potential upside, daily balance of power, and the relationship between the maximum drawdown and kurtosis , to decide if MAIA Biotechnology performance from the past will be repeated in the future.
Auto-correlation | -0.36 |
Poor reverse predictability
MAIA Biotechnology has poor reverse predictability. Overlapping area represents the amount of predictability between MAIA Biotechnology time series from 30th of October 2024 to 14th of November 2024 and 14th of November 2024 to 29th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of MAIA Biotechnology price movement. The serial correlation of -0.36 indicates that just about 36.0% of current MAIA Biotechnology price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.36 | |
| Spearman Rank Test | -0.31 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
MAIA Biotechnology lagged returns against current returns
Autocorrelation, which is MAIA Biotechnology stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting MAIA Biotechnology's stock expected returns. We can calculate the autocorrelation of MAIA Biotechnology returns to help us make a trade decision. For example, suppose you find that MAIA Biotechnology has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
MAIA Biotechnology regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If MAIA Biotechnology stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if MAIA Biotechnology stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in MAIA Biotechnology stock over time.
Current vs Lagged Prices |
| Timeline |
MAIA Biotechnology Lagged Returns
When evaluating MAIA Biotechnology's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of MAIA Biotechnology stock have on its future price. MAIA Biotechnology autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, MAIA Biotechnology autocorrelation shows the relationship between MAIA Biotechnology stock current value and its past values and can show if there is a momentum factor associated with investing in MAIA Biotechnology.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether MAIA Biotechnology offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of MAIA Biotechnology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Maia Biotechnology Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Maia Biotechnology Stock:Check out MAIA Biotechnology Correlation, MAIA Biotechnology Volatility and MAIA Biotechnology Alpha and Beta module to complement your research on MAIA Biotechnology. For information on how to trade MAIA Stock refer to our How to Trade MAIA Stock guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
MAIA Biotechnology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.